Overview

Represented a development stage biotech company in a going public "reverse merger" transaction, including a related pre-merger PIPE financing into the public company target.

Jump to Page

We use cookies on our website to improve functionality and performance, analyze website traffic, and enable social media features. By continuing to use our website, you agree to our use of cookies.